InfoNet Logo 

New Mexico AIDS InfoNet

Fact Sheet Number 513

PML (Progressive Multifocal

Leucoencephalopathy)


Eslabón a la Versión Español

 PrinterPrint

this Fact Sheet on a single page using:

 Microsoft Word

Adobe Acrobat

 More information on Downloading

& Printing Fact Sheets


WHAT IS PML?

Progressive multifocal leucoencepha- lopathy is a serious viral

infection of the brain.

“Encephalo” means brain, and “pathy” means

disease. Encephalopathy is a disease of the brain. “Leuco-”

means white. Leucoencephalopathy is a disease of the white matter

of the brain.

“Progressive” means that this disease gets worse

in a short time. “Multifocal” means that it shows up

in several places at the same time.

Researchers estimate that about 4% of people with AIDS develop

PML, especially if their T-cell

counts are below 100. The exact rate is hard to know because

PML is difficult to diagnose.

PML is fatal in about 90% of cases. People diagnosed with PML

live an average of 6 months. Most die within 2 years.

The “JC” virus causes PML. Most adults have been

exposed to JC virus and have no disease. In people with weakened

immune systems, JC virus can become active.


HOW CAN PML BE

DETECTED?

The symptoms of PML start with weakness or coordination problems

in an arm or leg. There may be difficulty thinking or speaking.

Vision and memory problems, seizures and headaches can occur.

These symptoms can also occur with other opportunistic infections,

including toxoplasmosis, lymphoma,

inner ear infections, or cryptococcal

meningitis. It is important to rule out these other diseases.

PML can be diagnosed using a magnetic resonance imaging (MRI)

scan of the brain. Another way to test for PML is by checking

spinal fluid. The sample is taken by inserting a needle into the

spinal canal, a procedure called a spinal tap.


HOW IS PML TREATED?

A major problem with treating any brain infection is the “blood-brain

barrier”. The blood vessels around the brain are different

from the rest of the body. They are “tightly woven”

to protect the brain from toxic substances. Chemicals that dissolve

in fat can get through. Those that dissolve in water can’t. Unfortunately,

this includes most antibiotics and many other medications.

There is currently no proven treatment for PML. Research studies

have had conflicting results, and other possible treatments have

not been carefully studied. However, PML has slowed down in some

patients taking combination antiviral therapy including a protease

inhibitor.

Ara-C (Cytosine arabinoside or cytarabine) has been tried against

PML. It was given intravenously, and also pumped directly into

the brain. It seemed to work in one small study, but not in later

ones. Ara-C is very toxic, and damages bone marrow.

High-dose AZT has been tried against

PML, because AZT can cross the blood-brain barrier. Other substances

that have been tried with different degrees of success include

acyclovir, heparin, peptide-T, beta interferon, dexamethasone,

and n-acetylcysteine, topotecan and cidofovir.

Because PML can progress rapidly, it is important to begin

treatments quickly.


WHERE CAN I GET

MORE INFORMATION?

An excellent source of information is the book, Progressive Multifocal

Leucoencephalopathy (PML): Case Studies and Potential Treatments.

Peter and Lisa Brosnan wrote the book in 1993. They are not medical

specialists, but Lisa’s brother was diagnosed with PML and the

Brosnans began searching for possible treatments. Lisa’s brother

died, but they continued and published their work.

You can get a copy of their book by writing to Peter Brosnan,

1709 N. Fuller Avenue #25, Los Angeles, CA 90046. To cover his

costs, he asks physicians and institutions to send $30, people

with AIDS $20, and in cases of hardship he will send it free.


THE BOTTOM LINE

PML is a viral infection of the brain. It is usually fatal. It

can be confused with other medical conditions.

There is no approved treatment for PML, although several treatments

may be helpful. Any treatment must be started as early as possible.

Combination antiviral therapy may slow the progress of PML.


Revised January 31, 2002

HomeGo

to InfoNet Main Page

Card FileGo to

Index of Fact Sheets

Question markClick

here if you have questions

The New Mexico AIDS InfoNet is a project of the

New Mexico AIDS Education and Training Center

Partially funded by the National Library of Medicine

and the New Mexico Department of Health